HIV infection and pregnancy

International Journal of STD and AIDS

Volumn 9, Issue 11, 1998, Pages 647-656

  De Ruiter, Annemiek ^a,c   Brocklehurst, Peter ^b  

^a GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c ST THOMAS HOSPITAL   (United Kingdom)

Author keywords

Antiretroviral; Caesarean section; HIV; Pregnancy

Indexed keywords

COTRIMOXAZOLE; NEVIRAPINE; RNA DIRECTED DNA POLYMERASE INHIBITOR; ZIDOVUDINE;

AFRICA SOUTH OF THE SAHARA; BIOLOGICAL MONITORING; BREAST FEEDING; COMBINATION CHEMOTHERAPY; DELIVERY; EMBRYO; FEMALE; GOVERNMENT; HEMOGLOBINOPATHY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; INTRAVENOUS DRUG ADMINISTRATION; MOTHER FETUS RELATIONSHIP; NEWBORN; NEWBORN HEMOLYTIC DISEASE; ORAL DRUG ADMINISTRATION; PNEUMOCYSTIS PNEUMONIA; PREGNANCY; PREGNANCY COMPLICATION; PRENATAL PERIOD; PRIORITY JOURNAL; REVIEW; SEXUAL BEHAVIOR; SOCIAL PSYCHOLOGY; TRANSPLACENTAL CARCINOGENESIS; VAGINA TUMOR; VERTICAL TRANSMISSION;

ANTI-HIV AGENTS; BREAST FEEDING; DELIVERY, OBSTETRIC; DISEASE TRANSMISSION, VERTICAL; DRUG THERAPY, COMBINATION; FEMALE; HIV INFECTIONS; HUMANS; INFANT, NEWBORN; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; PREGNANCY OUTCOME; PREVALENCE; VIRAL LOAD; ZIDOVUDINE;

EID: 0031791030     PISSN: 09564624     EISSN: None     Source Type: Journal    
DOI: 10.1258/0956462981921288     Document Type: Review

References (34)

1. Public Health Laboratory Service AIDS Centre. AIDS/HIV Quarterly Surveillance Tables 1997;37(97/3)
2. Nicoll A, McGarrigle C, Brady AR, et al. Epidemiology and detection of HIV-1 among pregnant women in the United Kingdom. BMJ 1998;316:253-8
3. Scott GB, Fischl MA, Klimas N, et al. Mothers of infants with the acquired immunodeficiency syndrome. JAMA 1985;253: 363-6
4. French R, Brocklehurst P. The effect of pregnancy on survival in women infected with HIV: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998; 105:827-35
5. Mercey D, Bewley S, Brocklehurst P. A Guide to HIV Infection and Childbearing, 2nd edn. Horsham: Avert, 1997
6. Marion RW, Wiznia AA, Hutcheon G, Rubenstein A. Human T-cell lymphotropic virus III (HTLV-III) embryopathy: a new dysmorphic syndrome associated with intrauterine HTLV-III infection. Am J Dis Child 1986;140: 638-40
7. Feldman JG, Minkoff HL, McCalla S, Salwen M. A cohort study of the impact of perinatal drug use on prematurity in an inner-city population. Am J Public Health 1992;82:726-8
8. Brocklehurst P, French R. The association between maternal HIV infection and perinatal outcome: a systematic review of the literature and meta-analysis. Br J Obstet Gynaecol 1998; 105:836-48
9. Lewis SH, Reynolds Kohler C, Fox HE, Nelson JA. HIV-1 in trophoblastic and villous Hofbauer cells, and haematological precursors in eight-week fetuses. Lancet 1990;335 (8689)565-8
10. Goedert J, Duliege A, Amos C, Felton S, Biggar R. High risk of HIV 1 infection for first born twins. Lancet 1991;338 (8781):1471-5
11. Scarlatti G. Paediatric HIV infection. Lancet 1996;348(9031): 863-8
12. Dunn DT, Newell ML, Ades AE, Peckham CS. Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 1992;340(8819):585-8
13. European Collaborative Study. Vertical transmission of HIV-1: maternal immune status and obstetric factors. AIDS 1996;10(14):1675-81
14. Ryder RW, Behets F. Reasons for the wide variation in reported rates of mother-to-child transmission of HIV-1. AIDS 1994;8(10):1495-7
15. Semba RD, Miotti PG, Chiphangwi JD, et al. Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 1994;343(8913):1593-7
16. European Collaborative Study. Risk factors for mother-to-child transmission of HIV-1. Lancet 1992;339(8800): 1007-12
17. Mayaux MJ, Dussaix E, Isopet J, et al. Maternal virus load during pregnancy and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohort studies. SEROGEST Cohort Group. J Infect Dis 1997;175(1):172-5
18. Sperling KS, Shapiro DE, Coombs RW, et al. Maternal viral load, zidovudine treatment and the risk of transmission of human immunodeficiency virus type 1 from mother to infant. N Engl J Med 1996;335(22):1621-9
19. Mandelbrot L, Mayaux MJ, Bongain A, et al. Obstetric factors and mother-to-child transmission of human immunodeficiency virus type 1: the French perinatal cohorts. Am J Obstet Gynecol 1996;175(3 Pt 1):661-7
20. Landesman SH, Kalish LA, Burns DN, et al. Obstetrical factors and the transmission of human immunodeficiency virus type 1 from mother to child. N Engl J Med 1996; 334(25):1617-23
21. Hannah ME, Ohlsson A, Farine D, et al. Induction of labour compared with expectant management for prelabour rupture of the membranes at term. N Engl J Med 1996; 334(16):1005-10
22. Johanson RB, Menon VJ. Vacuum extraction vs forceps delivery. In: Neilson JP, Crowther C, Hodnett ED, Hofmeyer GJ, eds. Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Available in The Cochrane Library. Issue 1 edition. Oxford: Update Software, 1998
23. Johanson RB. Soft vs hard vacuum extractor cups. In: Keirse MJNC, Renfrew MJ, Neilson JP, Crowther C, eds. Pregnancy and Childbirth Module of the Cochrane Pregnancy and Childbirth Database. Issue 2 edition. Oxford: Update Software, 1995
24. Drife J. Choice and instrumental delivery. Br J Obstet Gynaecol 1996;103:608-11
25. Carroli G, Belizan J, Stamp G. Episiotomy policies in vaginal births. In: Neilson JP, Crowther CA, Hodnctt ED, Hofmeyr GJ, eds. Pregnancy and Childbirth Module of the Cochrane Database of Systematic Reviews. Available in The Cochrane Library. Issue 1 edition. Oxford: Update Software, 1998
26. European Collaborative Study. Caesarean section and risk of vertical transmission of HIV-1 infection. Lancet 1994;343(8911):1464-7
27. Dunn DT, Newell ML, Mayaux MJ, et al. Mode of delivery and vertical transmission of HIV-1: a review of prospective studies. J Acquir Immune Defic Syndr 1994;7(10):1064-6
28. Minkoff H, Augenbraun M. Antiretroviral therapy for pregnant women. Am J Obstet Gynecol 1997;176(2):478-89
29. Mofenson L, Stiehm E, Lambert J, et al. Efficacy of zidovudine (ZDV) in reducing perinatal HIV-1 transmission in HIV-1 infected women with advanced disease. In. Proceedings of the 37th Interscience Conference on Antimicrobial Agents and Chemotherapy, (abstract)
30. Simpson BJ, Shapiro ED, Andiman WA. Reduction in the risk of vertical transmission of HIV-1 associated with treatment of pregnant women with orally administered zidovudine alone. J Acquir Immune Defic Syndr Hum Retrovirol 1997;14(2):145-52
31. Loveday C, Kaye S, Tenant Flowers M, et al. HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet 1995;345(8953):820-4
32. Administration of zidovudine during late pregnancy and delivery to prevent perinatal HIV transmission - Thailand 1996-1998. MMWR 1998;47(8):151-4
33. Delta Coordinating Committee. Delta: a randomised double-blind controlled trial comparing combinations of zidovudine plus didanosine or zalcitabine with zidovudine alone in HIV-infected individuals. Lancet 1996;348(9023):283-91
34. Public Health Service Task Force, Recommendations for the use of antiretroviral drugs in pregnant women infected with HIV-1 for maternal health and for reducing perinatal HIV-1 transmission in the United States. MMWR 1998;47 (RR-2)